当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Kcentra, Prothrombin Complex Concentrate (Human)
药品名称
Kcentra, Prothrombin Complex Concentrate (Human)
承诺描述
A retrospective observational cohort study to estimate the risk of thromboembolic events following Vitamin K Antagonist (VKA) reversal among patients treated with Kcentra or Plasma for urgent reversal of VKA therapy in the setting of acute major bleeding.